{
  "fund_code": "023930",
  "fund_name": "银华国证港股通创新药ETF发起式联接C",
  "holdings_asof_date": "2025-12-31",
  "stock_total_weight": 97.75,
  "parsed_weight": 71.51,
  "missing_weight": 26.24,
  "positions": [
    {
      "stock_code": "01093",
      "stock_name": "石药集团",
      "weight": 10.44
    },
    {
      "stock_code": "06160",
      "stock_name": "百济神州",
      "weight": 9.91
    },
    {
      "stock_code": "09926",
      "stock_name": "康方生物",
      "weight": 9.72
    },
    {
      "stock_code": "01177",
      "stock_name": "中国生物制药",
      "weight": 9.66
    },
    {
      "stock_code": "01801",
      "stock_name": "信达生物",
      "weight": 9.53
    },
    {
      "stock_code": "01530",
      "stock_name": "三生制药",
      "weight": 6.95
    },
    {
      "stock_code": "03692",
      "stock_name": "翰森制药",
      "weight": 6.93
    },
    {
      "stock_code": "06990",
      "stock_name": "科伦博泰生物-B",
      "weight": 3.48
    },
    {
      "stock_code": "00867",
      "stock_name": "康哲药业",
      "weight": 2.55
    },
    {
      "stock_code": "06855",
      "stock_name": "亚盛医药-B",
      "weight": 2.34
    }
  ],
  "fetched_at": "2026-02-21 23:51:44",
  "data_source": "eastmoney",
  "original_fund_code": "023930",
  "etf_target": "159567",
  "is_etf_link": true
}